SCA
TMO icon

Stuart Chaussee & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Stuart Chaussee & Associates’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-17
Closed -$11K – 187
2021
Q4 		$11K Buy
+17
New +$10.6K ﹤0.01% 118

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stuart Chaussee & Associates's TMO Position: Q1 2022 in Review

Stuart Chaussee & Associates sold out of Thermo Fisher Scientific (TMO) in Q1 2022, closing a stake of 17 shares — an estimated $11K sold.

Stuart Chaussee & Associates first reported a position in TMO in Q4 2021 and held it in 1 quarter. The position peaked at $11K in Q4 2021. 2,314 funds tracked by Wall St. Rank hold TMO as of Q1 2022.

  • Stuart Chaussee & Associates reported no remaining Thermo Fisher Scientific position as of Q1 2022 after selling out during the quarter.
  • Stuart Chaussee & Associates sold 17 Thermo Fisher Scientific shares in Q1 2022, an estimated $11K.
  • Stuart Chaussee & Associates first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 1 quarter.
  • Stuart Chaussee & Associates's Thermo Fisher Scientific position peaked at $11K in Q4 2021.
  • 2,314 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2022.

Based on Stuart Chaussee & Associates's 13F filing for Q1 2022, filed 12 Apr 2022.